Skip to content

Nocturnal Free Fatty Acids. Measurements in obese and lean subjects and the effect of â-blockage on pulsatile release.

Nocturnal Free Fatty Acids.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON21331
Enrollment
20
Registered
2008-11-19
Start date
2008-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

free fatty acid release vrije vetzuur afgifte

Interventions

Propranolol infusion

Sponsors

Academic Medical Center (AMC), Department of Endocrinology and Metabolism P.O. Box 22660 1100 DD Amsterdam The Netherlands +31 (0)20 5669111
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male obese subjects (BMI > 30 kg/m2) and healthy lean controls (BMI 20 > 25 kg/m2) 2. Age 20 – 50 years 3. Stable weight 3 months prior to study inclusion 4. Caucasian 5. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Any chronic medical condition or use of any medication 2. Asthma and bronchospastic COPD 3. Tobacco use 4. Alcohol abuse (>3/day) 5. Frequent intensive exercise (>2 week) 6. Familial lipid disorders, renal insufficiency (creatinine > 150 umol/L) , elevated liver enzymes (> 2 times), hypertension 7. Hypotension (BP < 100/60 mmHg), bradycardia (HR < 60min) 8. Unwilling or unable to provide informed consent 9. First degree family members with diabetes 10. Abnormal day/night rhythm (shiftworkers etc) 11. Blood donation in the past three months

Design outcomes

Secondary

MeasureTime frame
- Difference in nocturnal FFA levels between lean and obese subjects

Primary

MeasureTime frame
- Percent and/or absolute changes in nocturnal FFA levels with or without â-blockage.

Contacts

Public ContactB.A.M. Weijer, de

Academic Medical Center (AMC) Department of Endocrinology and Metabolism P.O. Box 22660 1100 DD

B.A.deWeijer@amc.uva.nl+31 (0)20 5666849

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)